National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting, 30723 [2020-10794]
Download as PDF
<![CDATA[
30723
Federal Register / Vol. 85, No. 98 / Wednesday, May 20, 2020 / Notices
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 14, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
[FR Doc. 2020–10794 Filed 5–19–20; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: June 9, 2020.
Open: 10:00 a.m. to 1:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 31, 31/4C32, 31 Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Virtual Access: https://videocast.nih.gov/
watch=37507.
Any member of the public may submit
written comments no later than 15 days after
the meeting.
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Bethesda, MD (Virtual Meeting).
Contact Person: Melinda Nelson, Director,
Office of Extramural Operations, National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, 45 Center Drive, Natcher
Building, Room 5A49, Bethesda, MD 20892,
(301) 594–3535, mn23z@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
VerDate Sep<11>2014
17:51 May 19, 2020
Jkt 250001
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of Quality
Custom Inspection and Laboratories,
Inc. (Pasadena, TX) as a Commercial
Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of Quality Custom Inspection
and Laboratories, Inc. (Pasadena, TX), as
a commercial gauger and laboratory.
AGENCY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Notice is hereby given,
pursuant to CBP regulations, that
Quality Custom Inspection and
Laboratories, Inc. (Pasadena, TX), has
been approved to gauge petroleum and
certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes for the next three years as of
September 6, 2018.
DATES: Quality Custom Inspection and
Laboratories, Inc. (Pasadena, TX) was
approved and accredited as a
commercial gauger and laboratory as of
September 6, 2018. The next triennial
inspection date will be scheduled for
September 2021.
FOR FURTHER INFORMATION CONTACT: Dr.
Eugene Bondoc, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW, Suite 1500N, Washington,
DC 20229, tel. 202–344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12
and 19 CFR 151.13, that Quality Custom
Inspection and Laboratories, Inc., 402
Pasadena Blvd., Pasadena, TX 77506,
has been approved to gauge petroleum
and certain petroleum products and
accredited to test petroleum and certain
petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.12 and 19 CFR
151.13.
Quality Custom Inspection and
Laboratories, Inc. (Pasadena, TX) is
approved for the following gauging
procedures for petroleum and certain
petroleum products from the American
Petroleum Institute (API):
SUMMARY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Emergency
Geriatrics Care.
Date: July 8, 2020.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Anita H. Undale, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, Suite 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (301) 827–
7428, anita.undale@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: May 14, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–10791 Filed 5–19–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
API chapters
3 ...................
7 ...................
8 ...................
11 .................
12 .................
17 .................
E:\FR\FM\20MYN1.SGM
20MYN1
Title
Tank Gauging.
Temperature Determination.
Sampling.
Physical Properties Data.
Calculations.
Marine Measurement.
]]>Agencies
[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Page 30723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10794]
[[Page 30723]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Arthritis
and Musculoskeletal and Skin Diseases Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: June 9, 2020.
Open: 10:00 a.m. to 1:00 p.m.
Agenda: To discuss program policies and issues.
Place: National Institutes of Health, Building 31, 31/4C32, 31
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
Virtual Access: https://videocast.nih.gov/watch=37507.
Any member of the public may submit written comments no later
than 15 days after the meeting.
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Bethesda, MD (Virtual
Meeting).
Contact Person: Melinda Nelson, Director, Office of Extramural
Operations, National Institute of Arthritis and Musculoskeletal and
Skin Diseases, 45 Center Drive, Natcher Building, Room 5A49,
Bethesda, MD 20892, (301) 594-3535, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research, National
Institutes of Health, HHS)
Dated: May 14, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-10794 Filed 5-19-20; 8:45 am]
BILLING CODE 4140-01-P
